Management of patients with HPV-positive and negative oropharyngeal squamous cell carcinoma
Evidence & Practice Previous     Next

Management of patients with HPV-positive and negative oropharyngeal squamous cell carcinoma

Morwenna Breeze-Milligan Staff nurse, Royal Marsden NHS Foundation Trust, London, England

A review of the impact of human papillomavirus (HPV)-positive squamous cell carcinoma of the head and neck on patients and their carers. Patients with HPV-mediated malignancy of the oropharynx present with distinct risk factors and a favourable prognosis compared to patients with HPV-negative disease. Despite the distinct clinical profile of HPV-positive malignancy, clinical recommendations do not account for HPV status. Consequently, patients with HPV-positive disease are receiving highly aggressive and often life-changing anti-cancer treatment despite a favourable prognosis.

Cancer Nursing Practice. 16, 3, 28-31. doi: 10.7748/cnp.2017.e1395

Correspondence

wennabreezemilligan@gmail.com

Peer review

This article has been subject to external double-blind peer review and checked for plagiarism using automated software

Conflict of interest

None declared

Received: 20 January 2017

Accepted: 02 March 2017

Want to read more?

Subscribe for unlimited access

Try 1 month’s access for just £1 and get:

Your subscription package includes:
  • Full access to the website and the online archive
  • Bi-monthly digital edition
  • RCNi Portfolio and interactive CPD quizzes
  • RCNi Learning with 200+ evidence-based modules
  • 10 articles a month from any other RCNi journal
Subscribe
RCN student member? Try Nursing Standard Student
Already subscribed? Log in

Alternatively, you can purchase access to this article for the next seven days. Buy now

Or